Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation

NANot yet recruitingINTERVENTIONAL
Enrollment

5,200

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

February 28, 2030

Study Completion Date

July 31, 2030

Conditions
Atrial Fibrillation on Apixaban Treatment
Interventions
OTHER

AF application enhancing AF education and drug adhrence

This group will use AF-application. The app will include content related to anticoagulation therapy, such as: medication reminders or intake confirmation for anticoagulants, the importance of anticoagulation therapy in stroke prevention, the role of antiarrhythmic and rate-control medications in symptom management, the necessity of controlling risk factors such as hypertension, diabetes, and hyperlipidemia, and quality of life and cognitive function assessments through questionnaires.

OTHER

AF application without enhancing AF education and drug adhrence

This group will use AF-application. However, this application will not contain materials enhancing AF education and adherence.

Trial Locations (1)

03722

Division of Cardiology Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT06869083 - Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter